查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1298711

經皮皮膚貼片市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Transdermal Skin Patches Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2022年，全球經皮皮膚貼劑市場規模達到76億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到100億美元，在2023-2028年期間呈現4.4%的成長率（CAGR）。

經皮皮膚貼劑指的是一種非侵入性的、易於使用的給藥方法，在預定的時間內將恆定和一致的治療劑量注入血液中。它們由背襯、藥物、膜、粘合劑、襯墊、化學增強劑和滲透劑、物理輔助劑和低電流（如離子透析）組成。它們提供穩定的擴散率，取決於皮膚的特點和貼片的設計。如今，它們在世界各地被廣泛用作化妝品、外用藥和經皮給藥系統。

經皮皮膚貼劑的市場趨勢：

經皮皮膚貼片對治療心臟和荷爾蒙紊亂、偏頭痛、帕金森氏症、阿滋海默症、中風、人類免疫缺陷病毒（HIV）、骨質疏鬆症和不寧腿綜合症很有效。因此，患有這些疾病的人口比例大幅增加是推動市場成長的關鍵因素之一。此外，這些藥貼有助於避免傳統的口服藥途徑，降低因靜脈或腸外治療造成的不便，並防止胃腸道毒性、噁心和嘔吐。此外，由於服用方便，經皮皮膚貼劑正在獲得牽引力，以提高病人在長期治療慢性疼痛和戒菸治療中的依從性。除此之外，人們對以可承受的成本獲得更好的治療方法的需求不斷升級，加上不同類別藥物的臨床試驗數量大幅增加，對市場產生了積極的影響。此外，壓敏膠和滲透增強劑的引入，導致產品擴散的增加和藥物保留能力的增強，預計將為市場參與者提供有利可圖的機會，並在未來幾年內擴大經皮皮膚貼片在全球的應用。

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球經皮皮膚貼劑市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按類型分類的市場

  • 單層粘附劑
    • 市場趨勢
    • 市場預測
  • 多層膠粘劑
    • 市場趨勢
    • 市場預測
  • 矩陣
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章：按配銷通路分類的市場

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥店
    • 市場趨勢
    • 市場預測
  • 網路商店
    • 市場趨勢
    • 市場預測

第8章：按用途分類的市場

  • 緩解疼痛
    • 市場趨勢
    • 市場預測
  • 減少吸煙和戒菸援助
    • 市場趨勢
    • 市場預測
  • 膀胱過度活動症
    • 市場趨勢
    • 市場預測
  • 荷爾蒙療法
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十一章：價值鏈分析

第十二章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十三章：價格分析

第十四章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • 3M Company
    • AdhexPharma
    • LTS Lohmann Therapie-Systeme AG
    • Luye Pharma Group
    • Medherant Limited
    • Nitto Denko Corporation
    • Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
    • Prosolus Inc.
    • Samyang Holdings Corporation
    • Tapemark
    • Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
    • tesa SE (Beiersdorf AG)
    • Teva Pharmaceutical Industries Ltd
Product Code: SR112023A5142

The global transdermal skin patches market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.4% during 2023-2028.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transdermal skin patches market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, distribution channel and application.

Breakup by Type:

Single-layer Drug-in-Adhesive

Multi-layer Drug-in-Adhesive

Matrix

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Breakup by Application:

Pain Relief

Smoking Reduction and Cessation Aid

Overactive Bladder

Hormonal Therapy

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group?, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. What was the size of the global transdermal skin patches market in 2022?

2. What is the expected growth rate of the global transdermal skin patches market during 2023-2028?

3. What are the key factors driving the global transdermal skin patches market?

4. What has been the impact of COVID-19 on the global transdermal skin patches market?

5. What is the breakup of the global transdermal skin patches market based on the type?

6. What is the breakup of the global transdermal skin patches market based on the application?

7. What are the key regions in the global transdermal skin patches market?

8. Who are the key players/companies in the global transdermal skin patches market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Transdermal Skin Patches Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Type

  • 6.1  Single-layer Drug-in-Adhesive
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Multi-layer Drug-in-Adhesive
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7   Market Breakup by Distribution Channel

  • 7.1  Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Online Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Application

  • 8.1  Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Smoking Reduction and Cessation Aid
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Overactive Bladder
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4  Hormonal Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5  Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2  AdhexPharma
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3  LTS Lohmann Therapie-Systeme AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4  Luye Pharma Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5  Medherant Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6  Nitto Denko Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7  Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8  Prosolus Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9  Samyang Holdings Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10  Tapemark
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11  Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12  tesa SE (Beiersdorf AG)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13  Teva Pharmaceutical Industries Ltd
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Transdermal Skin Patches Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Skin Patches Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Transdermal Skin Patches Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Transdermal Skin Patches Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Transdermal Skin Patches Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Transdermal Skin Patches Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Transdermal Skin Patches Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Transdermal Skin Patches (Matrix) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Transdermal Skin Patches (Matrix) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Transdermal Skin Patches (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Transdermal Skin Patches (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Transdermal Skin Patches (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Transdermal Skin Patches (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Transdermal Skin Patches (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Transdermal Skin Patches (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Transdermal Skin Patches (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Transdermal Skin Patches (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Transdermal Skin Patches (Pain Relief) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Transdermal Skin Patches (Pain Relief) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Transdermal Skin Patches (Overactive Bladder) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Transdermal Skin Patches (Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Transdermal Skin Patches (Hormonal Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Transdermal Skin Patches (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Transdermal Skin Patches (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Transdermal Skin Patches (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Transdermal Skin Patches Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Transdermal Skin Patches Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Transdermal Skin Patches Industry: SWOT Analysis
  • Figure 82: Global: Transdermal Skin Patches Industry: Value Chain Analysis
  • Figure 83: Global: Transdermal Skin Patches Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Skin Patches Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Transdermal Skin Patches Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Transdermal Skin Patches Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Transdermal Skin Patches Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Transdermal Skin Patches Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Transdermal Skin Patches Market: Competitive Structure
  • Table 7: Global: Transdermal Skin Patches Market: Key Players